You are here

Cohero Health Closes Series A Funding to Accelerate Commercial Expansion

Three Leaf Ventures leads investment round to bolster commercial business, expand clinical trials, and evolve BreatheSmart, the leading respiratory disease management platform.

New York, NY (PRWEB) November 02, 2016

Cohero Health, a digital health company that’s established leading connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has announced the closing of its $9M Series A financing. The funding round is led by Three Leaf Ventures, an affiliate of the Broe Group, with continuing participation from Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, and BioAdvance.

New investors include GIS Strategic Ventures, Heitkamp & Thumann Group, and P5 Health Ventures. Funds will be used to grow Cohero’s commercial business development efforts, expand its already robust clinical trial program, and evolve BreatheSmart, the company’s comprehensive connected platform.

Cohero Health remains the first and only company to enable tracking of controller medication, rescue medication and discern lung function in real-time, in an integrated comprehensive model.

Read Complete Article